News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
488,028 Results
Type
Article (8625)
Company Profile (143)
Press Release (479514)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (167481)
Career Advice (325)
Deals (25968)
Drug Delivery (7)
Drug Development (53119)
Employer Resources (15)
FDA (9834)
Job Trends (8751)
News (239310)
Policy (18091)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (1)
Academia (496)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33247)
ALS (113)
Alzheimer's disease (989)
Antibody-drug conjugate (ADC) (293)
Approvals (10500)
Artificial intelligence (342)
ASCO (160)
Autoimmune disease (224)
Automation (29)
Bankruptcy (264)
Belgium (2)
Best Places to Work (7121)
BIO (36)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (118)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (1)
Bladder cancer (140)
Brain cancer (31)
Breast cancer (521)
Cancer (3812)
Cardiovascular disease (227)
Career advice (260)
Career pathing (1)
CAR-T (181)
CDC (1)
CDMO (22)
Celiac Disease (1)
Cell therapy (495)
Cervical cancer (35)
Clinical research (48233)
Collaboration (1295)
Commercialization (3)
Compensation (1539)
Complete response letters (35)
COVID-19 (764)
CRISPR (64)
C-suite (816)
Cystic fibrosis (87)
Data (5932)
Denatured (4)
Depression (109)
Dermatology (73)
Diabetes (362)
Diagnostics (4226)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (160)
Drug pricing (8)
Drug shortages (2)
Duchenne muscular dystrophy (167)
Earnings (73888)
Editorial (2)
Employer branding (2)
Employer resources (15)
Events (88430)
Executive appointments (725)
FDA (12613)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (964)
Gene editing (126)
Generative AI (11)
Gene therapy (335)
GLP-1 (298)
Government (986)
Grass and pollen (2)
Guidances (283)
Healthcare (9382)
Hematology (99)
HIV (55)
Huntington's disease (23)
IgA nephropathy (70)
Immunology and inflammation (108)
Immuno-oncology (61)
Indications (165)
Infectious disease (956)
Inflammatory bowel disease (132)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (265)
Interviews (43)
IPO (12432)
IRA (2)
Job creations (2008)
Job search strategy (250)
JPM (3)
Kidney cancer (17)
Kidney disease (46)
Labor market (1)
Layoffs (71)
Legal (5257)
Licensing (20)
Liver cancer (45)
Longevity (21)
Lung cancer (551)
Lymphoma (265)
Machine learning (29)
Management (3)
Manufacturing (587)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8686)
Medtech (8846)
Mergers & acquisitions (14612)
Metabolic disorders (740)
mRNA (67)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (229)
Neuropsychiatric disorders (40)
Neuroscience (1897)
NextGen: Class of 2026 (3192)
Non-profit (850)
Now hiring (2)
Obesity (235)
Opinion (18)
Ovarian cancer (166)
Pain (180)
Pancreatic cancer (207)
Parkinson's disease (211)
Partnered (12)
Patents (506)
Patient recruitment (534)
Patient selection (4)
Peanut (32)
People (41624)
Peptides (3)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (15541)
Phase 2 (21533)
Phase 3 (14610)
Pipeline (7856)
Policy (19)
Postmarket research (1562)
Preclinical (6570)
Press Release (34)
Prostate cancer (194)
Psychedelics (8)
Radiopharmaceuticals (196)
Rare diseases (593)
Real estate (3054)
Recruiting (7)
Regenerative medicine (5)
Regulatory (15109)
Reports (23)
Research institute (587)
Resumes & cover letters (47)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (107)
Series A (167)
Series B (124)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2051)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (321)
Venture capital (18)
Weight loss (78)
Women's health (90)
Date
Last 7 days (296)
Last 30 days (1427)
Last 365 days (19108)
2026 (13982)
2025 (19325)
2024 (23068)
2023 (26610)
2022 (34746)
2021 (37308)
2020 (33606)
2019 (23456)
2018 (17671)
2017 (19025)
2016 (18272)
2015 (24364)
2014 (21715)
2013 (18146)
2012 (20238)
2011 (20451)
2010 (20322)
Location
Africa (238)
Alabama (80)
Alaska (2)
Arizona (313)
Arkansas (10)
Asia (18209)
Australia (2113)
California (12447)
Canada (3286)
China (554)
Colorado (504)
Connecticut (428)
Delaware (218)
Europe (25270)
Florida (1869)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (826)
India (52)
Indiana (326)
Iowa (16)
Japan (431)
Kansas (104)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1236)
Massachusetts (8139)
Michigan (315)
Minnesota (573)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (124)
New Hampshire (60)
New Jersey (2720)
New Mexico (12)
New York (2915)
North Carolina (1325)
North Dakota (4)
Northern California (6247)
Ohio (297)
Oklahoma (14)
Oregon (16)
Pennsylvania (2312)
Puerto Rico (23)
Rhode Island (30)
South America (414)
South Carolina (78)
South Dakota (1)
Southern California (5198)
Tennessee (126)
Texas (2031)
United States (40399)
Utah (377)
Vermont (1)
Virginia (159)
Washington D.C. (40)
Washington State (960)
West Virginia (1)
Wisconsin (76)
Wyoming (1)
488,028 Results for "allergan inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today’s Modern Aesthetics Practices
August 11, 2026
·
9 min read
Press Releases
Allergan Aesthetics Debuts AA Signature™ in the United States with SKIN360, Its First Multimodal Consultation Approach
September 22, 2026
·
15 min read
Press Releases
Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications
September 17, 2026
·
5 min read
Press Releases
Allergan Aesthetics to Advance Scientific Dialogue on Skin Longevity, Aging Biology and Exosome Science at the 2026 Science of Skin Summit
September 15, 2026
·
6 min read
Press Releases
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
August 4, 2026
·
12 min read
Press Releases
Allergan Aesthetics launches HArmonyCa® with Lidocaine, Canada’s first dual-action, next generation collagen-stimulating injectable
May 26, 2026
·
6 min read
Press Releases
Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
June 16, 2026
·
9 min read
Press Releases
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE), for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
July 17, 2026
·
11 min read
Press Releases
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
June 23, 2026
·
15 min read
Press Releases
Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco
March 26, 2026
·
23 min read
1 of 48,803
Next
